NuGen Medical Devices Inc. (TSXV:NGMD)

Market Cap	13.62M
Revenue (ttm)	1.08M
Net Income (ttm)	-1.83M
Shares Out	227.04M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,720
Average Volume	92,586
Open	0.0650
Previous Close	0.0600
Day's Range	0.0650 - 0.0650
52-Week Range	0.0400 - 0.1550
Beta	2.23
RSI	44.90
Earnings Date	Jun 5, 2025

About NuGen Medical Devices

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered i...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Lin Liang
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NGMD

Financial Performance

In 2024, NuGen Medical Devices's revenue was 1.01 million, an increase of 204.73% compared to the previous year's 331,403. Losses were -5.23 million, -44.18% less than in 2023.